Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Monocarboxylate transporters (MCTs) are a family of proton-linked plasma membrane transporters that facilitate the movement of monocarboxylates across biological membranes. They are crucial for CNS drug delivery due to their ability to transport both endogenous metabolites and certain drugs across the blood-brain barrier and into brain cells. MCTs play essential roles in energy metabolism, neuroenergetics, and maintaining neuronal survival under metabolic stress. Specific isoforms like MCT1, MCT2, and MCT4 have distinct expression patterns and functions within the CNS. Targeting or exploiting MCT-mediated pathways presents a promising strategy for enhancing CNS drug penetration.
Proton-coupled symport; some isoforms function as monocarboxylate exchangers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Monocarboxylate Transporters (MCTs).